A011801 (CompassHER2 RD): Postneoadjuvant T-DM1 + tucatinib/placebo in patients with residual HER2-positive invasive breast cancer Meeting Abstract
| Authors: | O'Sullivan, C. C. M.; Ballman, K. V.; McCall, L. M.; Zemla, T. J.; Weiss, A.; Mitchell, M.; Blinder, V. S.; Tung, N. M.; Irvin, W. J.; Lee, M.; Goetz, M. P.; Symmans, W. F.; Borges, V. F.; Krop, I. E.; Partridge, A. H.; Carey, L. A. |
| Abstract Title: | A011801 (CompassHER2 RD): Postneoadjuvant T-DM1 + tucatinib/placebo in patients with residual HER2-positive invasive breast cancer |
| Meeting Title: | 2021 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2021 Jun 4-8 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-05-20 |
| Language: | English |
| ACCESSION: | WOS:000708120306334 |
| DOI: | 10.1200/JCO.2021.39.15_suppl.TPS595 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS595 -- Source: Wos |
